217 related articles for article (PubMed ID: 33835414)
1. Psychometric assessment of EQ-5D-5L and ReQoL measures in patients with anxiety and depression: construct validity and responsiveness.
Franklin M; Enrique A; Palacios J; Richards D
Qual Life Res; 2021 Sep; 30(9):2633-2647. PubMed ID: 33835414
[TBL] [Abstract][Full Text] [Related]
2. Estimating Cost-Effectiveness Using Alternative Preference-Based Scores and Within-Trial Methods: Exploring the Dynamics of the Quality-Adjusted Life-Year Using the EQ-5D 5-Level Version and Recovering Quality of Life Utility Index.
Franklin M; Hunter RM; Enrique A; Palacios J; Richards D
Value Health; 2022 Jun; 25(6):1018-1029. PubMed ID: 35667775
[TBL] [Abstract][Full Text] [Related]
3. Enabling QALY estimation in mental health trials and care settings: mapping from the PHQ-9 and GAD-7 to the ReQoL-UI or EQ-5D-5L using mixture models.
Franklin M; Hernández Alava M
Qual Life Res; 2023 Oct; 32(10):2763-2778. PubMed ID: 37314661
[TBL] [Abstract][Full Text] [Related]
4. Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A.
Xu RH; Keetharuth AD; Wang LL; Cheung AW; Wong EL
Eur J Health Econ; 2022 Mar; 23(2):165-176. PubMed ID: 34338898
[TBL] [Abstract][Full Text] [Related]
5. Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients.
Breheny K; Hollingworth W; Kandiyali R; Dixon P; Loose A; Craggs P; Grzeda M; Sparrow J
Qual Life Res; 2020 Jul; 29(7):1935-1946. PubMed ID: 32080789
[TBL] [Abstract][Full Text] [Related]
6. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health.
Crick K; Al Sayah F; Ohinmaa A; Johnson JA
Qual Life Res; 2018 Jun; 27(6):1625-1633. PubMed ID: 29516342
[TBL] [Abstract][Full Text] [Related]
8. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.
O'Loughlin R; Jones R; Chen G; Mulhern B; Hiscock H; Devlin N; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):57-77. PubMed ID: 38329689
[TBL] [Abstract][Full Text] [Related]
9. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
[TBL] [Abstract][Full Text] [Related]
10. The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics.
Crossman-Barnes CJ; Sach T; Wilson A; Barton G
Qual Life Res; 2020 Mar; 29(3):619-627. PubMed ID: 31676971
[TBL] [Abstract][Full Text] [Related]
11. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
12. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
13. Examining the psychometric properties of a split version of the EQ-5D-5L anxiety/depression dimension in patients with anxiety and/or depression.
Belay YB; Mihalopoulos C; Lee YY; Mulhern B; Engel L
Qual Life Res; 2023 Jul; 32(7):2025-2036. PubMed ID: 36809437
[TBL] [Abstract][Full Text] [Related]
14. Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review.
Keetharuth AD; Hussain H; Rowen D; Wailoo A
Health Qual Life Outcomes; 2022 Sep; 20(1):139. PubMed ID: 36171595
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
Yfantopoulos J; Chantzaras A; Kontodimas S
Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371
[TBL] [Abstract][Full Text] [Related]
16. Validity of EQ-5D-5L in stroke.
Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
[TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the EQ-5D-5L in patients with major depression: factor analysis and Rasch analysis.
Bilbao A; Martín-Fernández J; García-Pérez L; Mendezona JI; Arrasate M; Candela R; Acosta FJ; Estebanez S; Retolaza A
J Ment Health; 2022 Aug; 31(4):506-516. PubMed ID: 33522336
[TBL] [Abstract][Full Text] [Related]
18. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
19. Validity of the EQ-5D-5L questionnaire among the general population of Poland.
Młyńczak K; Golicki D
Qual Life Res; 2021 Mar; 30(3):817-829. PubMed ID: 33099710
[TBL] [Abstract][Full Text] [Related]
20. Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia.
Michalowsky B; Hoffmann W; Xie F
J Alzheimers Dis; 2021; 83(1):77-87. PubMed ID: 34275901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]